Albumedix Ltd. (‘Albumedix’), a recognized global leader in recombinant human albumin specializing in the enablement of advanced therapies, announces the […]
The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is now established […]
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok